Structural basis for regulation of the Crk signaling protein by a proline switch

Nature Chemical Biology

Volumn 7, Issue 1, 2011, Pages 51-57

  Sarkar, Paramita ^a   Saleh, Tamjeed ^a   Tzeng, Shiou Ru ^a   Birge, Raymond B ^b   Kalodimos, Charalampos G ^a,c,d  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CRK PROTEIN; CYCLOPHILIN A; PROLINE; PROTEIN SH3; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; CIS TRANS ISOMERISM; CONFORMATIONAL TRANSITION; ISOMERIZATION; KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

EID: 78650486391     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.494     Document Type: Article

References (50)

1. Birge, R.B., Kalodimos, C., Inagaki, F. & Tanaka, S. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun. Signal. 7, 13 (2009).
2. Feller, S.M. Crk family adaptors-signalling complex formation and biological roles. Oncogene 20, 6348-6371 (2001).
3. Miller, C.T. et al. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene 22, 7950-7957 (2003).
4. Nishihara, H. et al. Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett. 180, 55-61 (2002). (Pubitemid 34242964)
5. Linghu, H. et al. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene 25, 3547-3556 (2006). (Pubitemid 43901676)
6. Shishido, T. et al. Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells 6, 431-440 (2001). (Pubitemid 32487454)
7. Sirvent, A., Benistant, C. & Roche, S. Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells. Biol. Cell 100, 617-631 (2008).
8. Feller, S.M., Knudsen, B. & Hanafusa, H. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13, 2341-2351 (1994). (Pubitemid 24985606)
9. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1993). (Pubitemid 23093884)
10. Wu, X. et al. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3, 215-226 (1995).
11. Sarkar, P., Reichman, C., Saleh, T., Birge, R.B. & Kalodimos, C.G. Proline cis-trans isomerization controls autoinhibition of a signaling protein. Mol. Cell 25, 413-426 (2007). (Pubitemid 46199288)
12. Kobashigawa, Y. et al. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat. Struct. Mol. Biol. 14, 503-510 (2007). (Pubitemid 46871805)
13. Reichman, C. et al. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain. Oncogene 24, 8187-8199 (2005). (Pubitemid 41759817)
14. Akakura, S. et al. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF. J. Cell. Physiol. 204, 344-351 (2005). (Pubitemid 40776837)
15. Kizaka-Kondoh, S., Matsuda, M. & Okayama, H. CrkII signals from epidermal growth factor receptor to Ras. Proc. Natl. Acad. Sci. USA 93, 12177-12182 (1996). (Pubitemid 26367115)
16. Ogawa, S. et al. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells. Oncogene 9, 1669-1678 (1994). (Pubitemid 24163394)
17. Nicholson, L.K. & Lu, K.P. Prolyl cis-trans Isomerization as a molecular timer in Crk signaling. Mol. Cell 25, 483-485 (2007). (Pubitemid 46274452)
18. Isakov, N. A new twist to adaptor proteins contributes to regulation of lymphocyte cell signaling. Trends Immunol. 29, 388-396 (2008).
19. Lu, K.P., Finn, G., Lee, T.H. & Nicholson, L.K. Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 3, 619-629 (2007). (Pubitemid 47417709)
20. Andreotti, A.H. Native state proline isomerization: an intrinsic molecular switch. Biochemistry 42, 9515-9524 (2003).
21. Göthel, S.F. & Marahiel, M.A. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell. Mol. Life Sci. 55, 423-436 (1999).
22. Brazin, K.N., Mallis, R.J., Fulton, D.B. & Andreotti, A.H. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc. Natl. Acad. Sci. USA 99, 1899-1904 (2002).
23. Wulf, G., Finn, G., Suizu, F. & Lu, K.P. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 7, 435-441 (2005). (Pubitemid 40637396)
24. Pastorino, L. et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440, 528-534 (2006).
25. Calabrese, M.F., Eakin, C.M., Wang, J.M. & Miranker, A.D. A regulatable switch mediates self-association in an immunoglobulin fold. Nat. Struct. Mol. Biol. 15, 965-971 (2008).
26. Lummis, S.C. et al. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 438, 248-252 (2005).
27. Nelson, C.J., Santos-Rosa, H. & Kouzarides, T. Proline isomerization of histone h3 regulates lysine methylation and gene expression. Cell 126, 905-916 (2006). (Pubitemid 44310777)
28. Wang, Z. et al. Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell 141, 1183-1194 (2010).
29. Eckert, B., Martin, A., Balbach, J. & Schmid, F.X. Prolyl isomerization as a molecular timer in phage infection. Nat. Struct. Mol. Biol. 12, 619-623 (2005). (Pubitemid 40980813)
30. Franke, E.K., Yuan, H.E. & Luban, J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359-362 (1994). (Pubitemid 24363437)
31. OuYang, B., Pochapsky, S.S., Dang, M. & Pochapsky, T.C. A functional proline switch in cytochrome P450cam. Structure 16, 916-923 (2008).
32. Vogel, M., Bukau, B. & Mayer, M.P. Allosteric regulation of Hsp70 chaperones by a proline switch. Mol. Cell 21, 359-367 (2006). (Pubitemid 43163531)
33. Severin, A., Joseph, R.E., Boyken, S., Fulton, D.B. & Andreotti, A.H. Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain. J. Mol. Biol. 387, 726-743 (2009).
34. Muralidharan, V. et al. Solution Structure and folding characteristics of the C-terminal SH3 domain of c-Crk-II. Biochemistry 45, 8874-8884 (2006). (Pubitemid 44100683)
35. Palmer, A.G. III. NMR characterization of the dynamics of biomacromolecules. Chem. Rev. 104, 3623-3640 (2004).
36. Mittermaier, A. & Kay, L.E. New tools provide new insights in NMR studies of protein dynamics. Science 312, 224-228 (2006).
37. Knudsen, B.S. et al. Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J. 14, 2191-2198 (1995).
38. Ren, R., Ye, Z.S. & Baltimore, D. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8, 783-795 (1994). (Pubitemid 24985779)
39. Mallis, R.J., Brazin, K.N., Fulton, D.B. & Andreotti, A.H. Structural characterization of a proline-driven conformational switch within the Itk SH2 domain. Nat. Struct. Biol. 9, 900-905 (2002).
40. Rosen, M.K. et al. Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374, 477-479 (1995).
41. Donaldson, L.W., Gish, G., Pawson, T., Kay, L.E. & Forman-Kay, J.D. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Proc. Natl. Acad. Sci. USA 99, 14053-14058 (2002). (Pubitemid 35257623)
42. Mayer, B.J., Hamaguchi, M. & Hanafusa, H. A novel viral oncogene with structural similarity to phospholipase C. Nature 332, 272-275 (1988). (Pubitemid 18076660)
43. Zvara, A. et al. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Oncogene 20, 951-961 (2001). (Pubitemid 32207112)
44. Li, S.S. Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem. J. 390, 641-653 (2005).
45. Vaynberg, J. et al. Structure of an ultraweak protein-protein complex and its crucial role in regulation of cell morphology and motility. Mol. Cell 17, 513-523 (2005). (Pubitemid 40269116)
46. Bax, A. & Grishaev, A. Weak alignment NMR: a hawk-eyed view of biomolecular structure. Curr. Opin. Struct. Biol. 15, 563-570 (2005). (Pubitemid 41393488)
47. Popovych, N., Tzeng, S.R., Tonelli, M., Ebright, R.H. & Kalodimos, C.G. Structural basis for cAMP-mediated allosteric control of the catabolite activator protein. Proc. Natl. Acad. Sci. USA 106, 6927-6932 (2009).
48. Schwieters, C.D., Kuszewski, J.J. & Clore, M.G. Using Xplor-NIH for NMR molecular structure determination. Prog. Nucl. Magn. Reson. Spectrosc. 48, 47-62 (2006).
49. Cornilescu, G., Delaglio, F. & Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302 (1999). (Pubitemid 29143535)
50. Tzeng, S.R. & Kalodimos, C.G. Dynamic activation of an allosteric regulatory protein. Nature 462, 368-372 (2009).